Form 4: Compass Pathways Director George Jay Goldsmith Reports Share Sales
SEC Form 4 Filing
George Jay Goldsmith, a director of Compass Pathways plc, reported the sale of ordinary shares through transactions on March 12 and 13, 2024, executed under a pre-arranged Rule 10b5-1 trading plan.
Summary
- George Jay Goldsmith, a director of Compass Pathways plc, filed a Form 4 detailing changes in beneficial ownership.
- On March 12, 2024, Goldsmith sold 15,740 ordinary shares at a weighted average price of $10.5803.
- Following this transaction, Goldsmith directly owns 4,079,107 ordinary shares.
- On the same day, Goldsmith's spouse sold 15,740 ordinary shares at a weighted average price of $10.5803.
- Following this transaction, Goldsmith's spouse indirectly owns 4,076,833 ordinary shares.
- On March 13, 2024, Goldsmith sold 17,203 ordinary shares at a weighted average price of $10.8049.
- Following this transaction, Goldsmith directly owns 4,061,904 ordinary shares.
- On the same day, Goldsmith's spouse sold 17,203 ordinary shares at a weighted average price of $10.8049.
- Following this transaction, Goldsmith's spouse indirectly owns 4,059,630 ordinary shares.
- The sales were executed automatically under Rule 10b5-1 trading plans adopted on August 23, 2023.
- Goldsmith and his spouse disclaim beneficial ownership of each other's shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transactions were pre-planned under a Rule 10b5-1 trading plan and do not necessarily reflect a change in the director's outlook on the company.
Industry Context
Sales by company insiders are a common occurrence, but investors often monitor these transactions for signals about management's confidence in the company's future prospects. Sales under a pre-arranged 10b5-1 trading plan are less likely to be indicative of management sentiment, as they are often established for personal financial planning reasons.
Stakeholder Impact
- The share sales by a director and their spouse could be perceived negatively by some shareholders, potentially leading to a slight decrease in investor confidence.
- However, the disclosure that these sales were pre-planned under a Rule 10b5-1 trading plan may mitigate any negative impact.
Key Dates
| Date | Description |
|---|---|
| 2023/08/23 | Date of adoption of Rule 10b5-1 trading plans by Mr. Goldsmith and Dr. Malievskaia |
| 2024/03/12 | Date of first reported share sales by Mr. Goldsmith and Dr. Malievskaia |
| 2024/03/13 | Date of second reported share sales by Mr. Goldsmith and Dr. Malievskaia |
| 2024/03/14 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.